Characterization of Individuals Interested in Participating in a Phase I SARS-CoV-2 Vaccine Trial

The development of an effective vaccine against SARS-CoV-2 marks one of the highest priorities during the ongoing pandemic. However, recruitment of participants for clinical trials can be challenging, and recruitment failure is among the most common reasons for discontinuation in clinical trials. Fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Shamsrizi, Parichehr, Kramer, Frederik Johannes, Addo, Marylyn Martina, Fathi, Anahita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538230/
https://www.ncbi.nlm.nih.gov/pubmed/34696316
http://dx.doi.org/10.3390/vaccines9101208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538230/
https://www.ncbi.nlm.nih.gov/pubmed/34696316
http://dx.doi.org/10.3390/vaccines9101208

Ejemplares similares